These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30374692)

  • 1. ACTH and cortisol responses to CRH in acute, subacute, and prolonged critical illness: a randomized, double-blind, placebo-controlled, crossover cohort study.
    Peeters B; Meersseman P; Vander Perre S; Wouters PJ; Debaveye Y; Langouche L; Van den Berghe G
    Intensive Care Med; 2018 Dec; 44(12):2048-2058. PubMed ID: 30374692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M; Allolio B; Würth G; Winkelmann W
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of pro-opiomelanocortin in the ACTH-cortisol dissociation of sepsis.
    Téblick A; Vander Perre S; Pauwels L; Derde S; Van Oudenhove T; Langouche L; Van den Berghe G
    Crit Care; 2021 Feb; 25(1):65. PubMed ID: 33593393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction.
    Donald RA; Crozier IG; Foy SG; Richards AM; Livesey JH; Ellis MJ; Mattioli L; Ikram H
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):499-504. PubMed ID: 8187316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
    Schroeder S; Wichers M; Klingmüller D; Höfer M; Lehmann LE; von Spiegel T; Hering R; Putensen C; Hoeft A; Stüber F
    Crit Care Med; 2001 Feb; 29(2):310-6. PubMed ID: 11246311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late feedback effects of hypothalamic-pituitary-adrenal axis hormones in healthy subjects.
    Posener JA; Schildkraut JJ; Williams GH; Schatzberg AF
    Psychoneuroendocrinology; 1998 May; 23(4):371-83. PubMed ID: 9695137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous administration of human corticotropin-releasing hormone in the absence of glucocorticoid feedback in man.
    Ur E; Capstick C; McLoughlin L; Checkley S; Besser GM; Grossman A
    Neuroendocrinology; 1995 Feb; 61(2):191-7. PubMed ID: 7753338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans.
    Grottoli S; Maccagno B; Ramunni J; Di Vito L; Giordano R; Gianotti L; DeStefanis S; Camanni F; Ghigo E; Arvat E
    J Endocrinol Invest; 2002 May; 25(5):420-5. PubMed ID: 12035937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans.
    Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):441-3. PubMed ID: 8582096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans.
    Gianotti L; Ramunni J; Lanfranco F; Maccagno B; Giordano R; Broglio F; Maccario M; Muller EE; Ghigo E; Arvat E
    J Endocrinol Invest; 2001 Feb; 24(2):67-71. PubMed ID: 11263473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Insufficient Sleep on Pituitary-Adrenocortical Response to CRH Stimulation in Healthy Men.
    Guyon A; Morselli LL; Balbo ML; Tasali E; Leproult R; L'Hermite-Balériaux M; Van Cauter E; Spiegel K
    Sleep; 2017 Jun; 40(6):. PubMed ID: 28444400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline and CRH-stimulated ACTH and cortisol levels after administration of the peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone, in Cushing's disease.
    Cannavò S; Ambrosi B; Chiodini I; Vigo T; Russo A; Milici C; Barbetta L; Dall'Asta C; Adda G; Arosio M
    J Endocrinol Invest; 2004 May; 27(5):RC8-11. PubMed ID: 15279069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone, AVP and hypoglycaemia.
    Hohnloser J; Von Werder K; Müller OA
    Clin Endocrinol (Oxf); 1989 Aug; 31(2):175-84. PubMed ID: 2557988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients.
    Hotta M; Shibasaki T; Masuda A; Imaki T; Demura H; Ling N; Shizume K
    J Clin Endocrinol Metab; 1986 Feb; 62(2):319-24. PubMed ID: 3001125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsivity of the baboon fetal pituitary to corticotropin-releasing hormone in utero at midgestation.
    Berghorn KA; Albrecht ED; Pepe GJ
    Endocrinology; 1991 Sep; 129(3):1424-8. PubMed ID: 1651849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.